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Background:The role of intracellular lipidmetabolism as it relates to nutrient-coupled glucose-stimulated insulin secretion
has not been fully elucidated.
Results: Knockdown of acyl-CoA synthetase isoform 4 impairs glucose-stimulated insulin secretion caused by decreased
cellular epoxyeicosatrienoic acids.
Conclusion: Acyl-CoA synthetase 4 is required for optimal glucose-stimulated insulin secretion.
Significance: Understanding the role of beta-cell lipid metabolism is needed to develop novel strategies to enhance insulin
secretion.
Glucose-stimulated insulin secretion (GSIS) in pancreatic
beta-cells is potentiated by fatty acids (FA). The initial step in
themetabolismof intracellular FA is the conversion to acyl-CoA
by long chain acyl-CoA synthetases (Acsls). Because the pre-
dominantly expressed Acsl isoforms in INS 832/13 cells are
Acsl4 and -5, we characterized the role of theseAcsls in beta-cell
function by using siRNA to knock down Acsl4 or Acsl5. Com-
pared with control cells, an 80% suppression of Acsl4 decreased
GSIS and FA-potentiated GSIS by 32 and 54%, respectively.
Knockdown of Acsl5 did not alter GSIS. Acsl4 knockdown did
not alter FA oxidation or long chain acyl-CoA levels.WithAcsl4
knockdown, incubation with 17 mM glucose increased media
epoxyeicosatrienoic acids (EETs) and reduced cell membrane
levels of EETs. Further, exogenous EETs reduced GSIS in INS
832/13 cells, and in Acsl4 knockdown cells, an EET receptor
antagonist partially rescued GSIS. These results strongly sug-
gest that Acsl4 activates EETs to form EET-CoAs that are incor-
porated into glycerophospholipids, thereby sequestering EETs.
Exposing INS 832/13 cells to arachidonate or linoleate reduced
Acsl4 mRNA and protein expression and reduced GSIS. These
data indicate that Acsl4modulates GSIS by regulating the levels
of unesterified EETs and that arachidonate controls the expres-
sion of its activator Acsl4.
Insulin secretion frombeta-cells in the islets of Langerhans is
a complex process initiated by nutrient secretagogues, includ-
ing glucose, amino acids, and fatty acids (FA).2 McGarry and
co-workers (1, 2), in classic experiments, showed that FA are
essential for insulin secretion, because glucose-stimulated
insulin secretion (GSIS) was diminished when nicotinic acid
infusion deprived rats of circulating free FA. Conversely, when
plasma-free FA are elevated by an infusion of lard oil plus hep-
arin, insulin secretion is supranormal. Other studies designed
to evaluate the role of long chain acyl-CoAs in INS-1 cells and
rat islets also support the concept that lipids acutely stimulate
GSIS (3–5). FA appear to augmentGSIS by at least two separate
mechanisms: 1) activation of the G-protein-coupled receptor,
GPR40, resulting in increased intracellular calcium (6, 7), and 2)
increasing intracellular levels of FA metabolites (8), whose
mechanism of action has remained uncertain.
Arachidonate (AA; 20:46) is normally esterified to glycero-
phospholipids and represents 30% of the fatty acid mass in
pancreatic islet glycerophospholipids (9). Based on studies that
show that glucose stimulates the release andmetabolism of AA,
it has been hypothesized that AA and/or its metabolites play a
significant role in insulin secretion (10–12). The initial hydrol-
ysis of AA from glycerophospholipids seems to be critical for
insulin secretion, because knockdown or knock-out of phos-
pholipase A2 in INS-1 cells (13) or mouse islets (14) diminishes
GSIS. Free AA is metabolized by one of several different
enzyme systems that yield potent bioactive compounds with
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critical signaling roles. Isolated pancreatic islets produce pros-
taglandins, leukotrienes, thromboxanes, hydroxyeicosatetra-
enoic acids (HETEs), and epoxyeicosatrienoic acids (EETs) (10,
15, 16). Glucose stimulates the synthesis of 12-HETE, and
inhibiting 12-HETE synthesis in isolated rat islets suppresses
GSIS. Similarly, different EET species also alter beta-cell func-
tion. Thus, 5,6-EET, but not 8,9-, 11,12-, or 14,15-EET, stimu-
lates insulin secretion in isolated rat islets (17), and 8,9-, 11,12-,
and 14,15-EET stimulate glucagon release from the same islets.
Although AA and its metabolites play a role in GSIS, it is not
understood how thesemetabolites are regulated in the beta-cell
or how they might stimulate or impair insulin secretion.
Central to the intracellular metabolism of fatty acids is their
activation by one of a family of five long chain acyl-CoA synthe-
tases (Acsl1, 3–6). Each of the long chain acyl-CoA synthetases
is encoded by a separate gene and differs in substrate prefer-
ence, enzyme kinetics, subcellular location, and tissue-specific
expression (18). Activation to an acyl-CoA is required before
FA can be oxidized for ATP production, esterified for the syn-
thesis of glycerolipids or cholesterol esters, or used in a signal-
ing pathway. Both loss of function and gain of function studies
suggest that eachAcsl isoform is distinct in directing acyl-CoAs
to one ormore specific pathways. For example, Acsl1 deficiency
in adipose or heart does not alter glycerolipid synthesis but
profoundly diminishes FA oxidation (19, 20).
A stimulatory role for acyl-CoAs in GSIS has been hypothe-
sized (3), but the Acsl isoforms that synthesize acyl-CoAs and
their role in regulating FA flux and FAmetabolites in beta-cells
have not been directly examined. Using INS 832/13 insulinoma
cells, we show that knocking down Acsl4 impairs GSIS by
increasing free EETs, that direct incubation of INS 832/13 cells
with EETs reduces insulin secretion, and that Acsl4 activates
EETs to produce EET-CoAs that may then be re-esterified into
glycerophospholipids.
EXPERIMENTAL PROCEDURES
Materials—[1-14C]Palmitic acid and [1-14C]oleic acid were
purchased from PerkinElmer Life Sciences (Waltham, MA).
[1-14C]Arachidonic acid was purchased fromAmerican Radio-
labeled Chemicals (St. Louis, MO). ()-5,6-EET, ()-8,9-EET,
()-11,12-EET, ()-14,15-EET, and 14,15-EEZE were pur-
chased from Cayman Chemical (Ann Arbor, MI). All other
chemicals and reagents were purchased from Sigma unless oth-
erwise specified. Silica-gel G plates were from Whatman
(Springfield Mill, UK).
Cell Culture—INS 832/13 rat insulinoma cells were cultured
(21) and used at passage numbers between 43 and 60.
siRNATransfection—Duplex siRNAswere designed and syn-
thesized by IntegratedDNATechnologies (Coralville, IA). Tar-
gets against rat Acsl4 (GenBankTM accession number
NM_053623.1) were nucleotide positions 283–307 and 3377–
3401 for siAcsl4-1 and siAcsl4-2, respectively. The target
sequence against rat Acsl5 (GenBankTM accession number
NM_053607.1) was nucleotide positions 784–808.Nonspecific
siRNA, siControl (AAGTCGGTTAAACGTTGGCAT), served
as control. The cells were transfected with DharmaFect reagent
1 (Dharmacon Products, Lafayette, CO) per themanufacturer’s
specifications with a final duplex siRNA concentration of 25
nM. Briefly, 24 h after cells were plated at the appropriate den-
sities, they were treated with siRNAs for 48 h, after which the
mediumwas changed, and experiments were performed on the
treated cells 24 h later.
Quantitative Real Time RT-PCR—Total RNA was extracted
from INS 832/13 cells using TRIzol (Invitrogen) and reverse
transcribed with a high capacity cDNA archive kit (Applied
Biosystems, Foster City, CA). cDNAwas amplified by real time
PCR in a total reaction volume of 25 l using Absolute QPCR
Sybr Green Fluorescein Mix (ThermoScientific, Waltham,
MA). Primer sets are identified in Table 1. PCR amplifications
were performed in an iCycler detection system (Bio-Rad). Tar-
get gene expression was normalized to endogenous beta-actin
and expressed as 2Ct.
Western Blot Analysis—The cells were homogenized in lysis
buffer (20mMTris, 150mMNaCl, 1mMEDTA, 1mMEGTA, 50
mMNaF, 2.5mMNa4P2O710H2O, 1%TritonX-100, andCom-
plete Mini Protease Inhibitor Mixture; Roche Applied Science,
Indianapolis, IN). Equal amounts of protein (40 g) were
loaded and resolved on 8% SDS-polyacrylamide gels and trans-
ferred to nitrocellulose membranes. Blots were probed with
antibodies against Acsl4 (Santa Cruz Biotechnology, Dallas,
TX) or rabbit anti-human ACSL4 (22), a generous gift from
S.M. Prescott (University of Utah, Salt Lake, UT), Acsl5 (Novus
Biologics, Littleton, CO), and Gapdh for the loading control
(Pierce). Densitometry was performed using ImageJ, where the
protein of interest was normalized to Gapdh loading control.
ACS Activity Assay—ACS activity was measured in INS
832/13 cell total membrane fractions (4 to 10 g) at 25 °C using
an isotopic method with either 50 M [1-14C]palmitic acid,
[1-14C]oleic acid, or [1-14C]arachidonic acid, 10 mM ATP, and
0.25mMCoA (23). An indirect ACS activity assay using synthe-
sized and purified recombinant rat FLAG-Acsl4 (24) with dif-
ferent substrates was performed spectrophotometrically (25).
Flux Studies—Incorporation of oleate or AA into cellular lip-
ids was measured in INS 832/13 cells after siAcsl4 knockdown.
Using 6-well plates, transfected cells were incubated for 4 h
with 0.25 Ci of [1-14C]oleic acid or [1-14C]arachidonic acid in
the presence of 100 M unlabeled oleate or AA, respectively.
TABLE 1
Gene Forward primer Reverse primer GenBankTM accession number
-Actin GGCTCCTAGCACCATGAAGA GAAAGGGTGTAAAACGCAGC NM_031144
Acsl1 GTTCCGAAGAATGACCTGGA TTCTGAAGACATGCTGTGCC NM_012820.1
Acsl3 CTCCACTTTCTGCAACGACA TCTGCCGGTATTGTAGTCCC NM_057107.1
Acsl4 GAGGCTGAATTGCTCCTTTG TCAGCAACAGCAAACAGACC NM_053623.1
Acsl5 TGACACACTGGGAGCAGAAG CAGGTCATCATCGAAAGGGT NM_053607.1
Acsl6 TGGGGAAAGAAAGTGGACTG AAACTTTGCTGGGCTGAGAA NM_130739.1
Cyp2j4 CGCACCGCATCTGTGCTGTC GCAAAGGCACGCCACTGAGC NM_023025.2
Ephx2 GGCGCTGCCCAGAGACTTCC GCCTGAAGCATGGGGCGGTT NM_022936.1
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The lipids were extracted and separated by thin layer chroma-
tography (26). Labeled lipid productswere visualized and quan-
tified using a BioScan Image 200 System (Washington, DC).
Insulin Secretion Studies—To assay insulin secretion, INS
832/13 cells were transfected as described above at 3.5  105
cells/well in 12-well tissue culture dishes. After 72 h, the cells
were washed in Hanks’ balanced salt solution with 0.2% bovine
serum albumin and 3 mM glucose followed by preincubation in
1 ml of the same buffer for 1 h. Insulin secretion was measured
by static incubation of the cells for 2 h in 1 ml of Hanks’ bal-
anced salt solution containing glucose, oleate/palmitate (2:1
molar ratio), oleate, palmitate, AA, KCl, or 14,15-epoxyeicosa-
5(Z)-enoic acid (14,15-EEZE; Cayman Chemicals, Ann Arbor,
MI) at the concentrations indicated in the figure legends. In
experiments with EET exposure, INS 832/13 cells were grown
to confluence in 12-well plates and exposed to 1MEET species
in both the preincubation buffer and the stimulation buffer.
Insulin released into the stimulation buffer wasmeasured using
an enzyme-linked immunosorbent assay (rat/mouse insulin
ELISA; Millipore, Billerica, MA, catalog number EZRMI-13K)
and normalized to total cellular protein.
MeasurementofPalmitateOxidation—Fatty acidoxidationwas
determined by measuring 14CO2 and acid-soluble metabolites
produced from[1-14C]palmitate in siControl andsiAcsl4cells (19).
Extraction and Analysis of Media and Cellular Eicosanoids—
Following a 48-h siRNA treatment, the cell mediumwas changed.
Twenty-four hours later the mediumwas collected and stored on
ice until extraction. Cell lipids were saponified (27). Briefly, the
cells were scraped from plates with 0.2 N methanolic NaOH and
heated to 50 °C for 2 h. After cooling to room temperature, PBS
was added to bring the pH to 8.0. The saponified lipid products
andmedia lipidswere extracted twicewith ethyl ether after adding
internal standards (30 ng of prostaglandin E2-d4, 10,11-dihy-
droxynonadecanoic acid, and 10,11-epoxyheptadecanoic acid
(Cayman Chemicals)) and butylated hydroxytoluene. Media and
cellular eicosanoid levels were quantified by liquid chromatogra-
phywith anAgilent 1200 Series capillaryHPLC (Agilent Technol-
ogies, Santa Clara, CA). The samples were analyzed in triplicate.
Negative ion electrospray ionization tandem mass spectrometry
wasused fordetection.AnalyseswereperformedonanMDSSciex
API 3000 equippedwith aTurboIonSpray source (AppliedBiosys-
tems, Foster City, CA) (28).
Extraction and Quantification of Long Chain Acyl-CoAs—
Cellular long chain acyl-CoAs were extracted, purified, and ana-
lyzed as described (29–31). The acyl-CoAs were analyzed by flow
injection analysis using positive electrospray ionization on Quat-
tromicro, triple quadrupolemass spectrometer (Waters,Milford,
MA). Heptadecanoyl CoAwas employed as an internal standard.
Statistical Analysis—The data are expressed as means  S.E.
Thesignificanceofdatawasdeclaredatp0.05byStudent’s t test.
RESULTS
Acsl5 siRNA Suppresses Acsl5 mRNA and Protein but Does
Not Affect GSIS—Profiling of AcslmRNA expression by quan-
titative PCR in INS-1 832/13 revealed that Acsl4 and -5 are the
predominantly expressed Acsl isoforms; Acsl1, -3, and -6 were
expressed at lower levels (Fig. 1A). To determine the role of the
major Acsls in INS 832/13 cell lipid metabolism and to deter-
mine whether their activity plays a role in insulin secretion, we
used siRNAs to knock down either Acsl4 or Acsl5. A siRNA
targeted against Acsl5 reduced the level of Acsl5 mRNA by
more than 80% and reduced Acsl5 protein expression by 30%
relative to siControl (Fig. 1, B and C), but the expression of
Acsl4 mRNA did not significantly change, and glucose-stimu-
lated insulin secretion was not significantly altered (Fig. 1D).
These data indicate that, despite being expressed at a level
higher than any of the other Acsl isoforms, Acsl5 in INS 832/13
cells does not play a role in GSIS.
Acsl4 siRNA Effectively Suppressed Acsl4 Expression and Cel-
lular Acsl Activity—To determine the role of Acsl4 in INS
832/13 cell lipid metabolism and insulin secretion, two siRNAs
targeted against Acsl4 reduced the level of Acsl4 mRNA by
more than 75% (Fig. 2A). This knockdown of Acsl4 did not
significantly change the expression of Acsl5mRNA, indicating
that Acsl5 did not compensate for the Acsl4 deficiency. Like-
wise, the other Acsl isoforms (1, 3, and 6) and fatty acid trans-
port proteins (Fatp4 and Fatp5) mRNAs were unaffected (data
not shown). Both of theAcsl4 siRNAs reduced the level of Acsl4
protein expression after transfection by greater than 80% (Fig.
2B). Acsl specific activity in total cell membranes was then
measured with three different FA substrates, AA, palmitate,
and oleate (32). Knockdown of Acsl4 significantly decreased
Acsl specific activity by 57% for AA, 46% for palmitate, and 53%
for oleate (Fig. 2C). Residual Acsl activity results from the other
Acsl isoforms that are still expressed and remain functional.
Interestingly, compared with both palmitate and oleate, AA
gave the highest Acsl specific activity, as suggested previously
(32), and its activity was diminished the most by siAcsl4. These
data suggest that in INS 832/13 cells, Acsl4 contributes approx-
imately half of the total cellular Acsl activity.
Acsl4 Knockdown Reduced Both GSIS and FA-augmented
GSIS—Given the substrate preference and tissue distribution of
Acsl4 (32, 33), we evaluated the effect of Acsl4 knockdown on
insulin secretion. In the presence of various secretagogues,
including glucose, specific fatty acids, and KCl, knockdown of
Acsl4 expression significantly reduced insulin secretion (Fig.
2D). In siAcsl4 knockdown cells stimulated solely with 17 mM
glucose, GSIS was reduced by 32%. Further, the addition of a
combination of oleate and palmitate in a physiologic 2:1 unsat-
urated:saturatedmolar ratio increased insulin secretion relative
to the effect of glucose alone. However, in all treatment groups
comparedwith the siControl cells, the siAcsl4 cells secreted less
insulin. In both siControl and siAcsl4 cells, the differential rise
in insulin secretion with exogenous FA was likely due to the
known effects of GPR40 on FA-augmented insulin secretion
(7). Likewise, in siAcsl4 cells relative to siControl, the reduction
in insulin secretion was probably due to generation of FA
metabolites with signaling properties formed from AA. These
results indicate that a single specific Acsl isoform, Acsl4, medi-
ates the majority of intracellular Acsl activity and that normal
GSIS requires Acsl4 activity.
Knockdown of Acsl4 Altered the Incorporation of Arachido-
nate into Neutral Lipids and Increased Palmitate Oxidation—
To further characterize the consequences ofAcsl4 knockdown,
we evaluated the incorporation of oleate and AA into neutral
lipids and phospholipids. Incorporation of oleate into total
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glycerolipids was not affected by the knockdown of Acsl4 (Fig.
3A), and no changes were observed in the incorporation of
oleate into neutral lipids (triacylglycerol, diacylglycerol, or cho-
lesterol esters) (Fig. 3C), or phospholipids (Fig. 3E). However,
Acsl4 knockdown resulted in 20% lower incorporation of AA
into total lipids (Fig. 3B) with a 51% reduction in its incorpora-
tion into neutral lipids (Fig. 3D), without altering the incorpo-
ration of AA into phospholipids (Fig. 3F). These results suggest
that Acsl4 preferentially channels arachidonate toward the syn-
thesis of specific intracellular glycerolipids.
We evaluated the effect ofAcsl4 knockdownon the oxidation
of palmitate at basal and stimulatory glucose concentrations (3
or 17 mM glucose) to determine whether a defect in FA oxida-
tionmight have reduced insulin secretion. Consistent with pre-
vious studies (34), in siControl and siAcsl4 cells, the oxidation
of palmitate was greater at low glucose concentrations than at
higher glucose concentrations (Fig. 3, G and H). Surprisingly,
however, at both 3 and 17 mM glucose, knockdown of Acsl4
increased the oxidation of palmitate. Thus, a defect in FA oxi-
dation did not cause the reducedGSIS of theAcsl4 knockdown.
Additionally, these studies suggest that knocking down Acsl4
diverted palmitate toward oxidative metabolism.
Knockdown of Acsl4 Did Not Alter Content of Total CoA or
Long Chain Acyl-CoA Species—To understand whether lack of
Acsl4would alter the fatty acid composition of INS 832/13 cells,
we measured both total CoA and long chain acyl-CoA species
by LC-MS/MS, expecting that the knockdown of Acsl4 would
result in a decrease in long chain acyl-CoA species, especially
arachidonyl-CoA. However, siControl and siAcsl4 cells did not
significantly differ in their content of either total CoA or long
chain acyl-CoA species (Fig. 4,A and B) compared with control
vehicle-treated cells that were devoid of supplemental FA. To
FIGURE 1. Acsl4 and Acsl5 are the predominant Acsl isoforms in INS 832/13 cells. Glucose-stimulated insulin secretion was not reduced by Acsl5 knock-
down. A, relative mRNA expression of Acsl isoforms in INS 832/13 cells. B, a siRNA targeted against Acsl5 reduced mRNA expression by 90%. C, corresponding
reduction of Acsl5 protein expression by 30% as quantified by densitometry relative to Gapdh loading control. A.U., arbitrary units. D, siRNA knockdown of
Acsl5 had no significant effect on glucose stimulated insulin secretion with or without KCl. The results represent means  S.E. of three separate experiments
carried out at least in triplicate. *, p  0.05 relative to siControl.
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ensure that the knockdown of Acsl4 was specific for the reduc-
tion in arachidonyl-CoA, siControl and siAcsl4 cells were incu-
bated for 4 h with either 50 M oleate or AA. The addition of
exogenous FA increased the total acyl-CoA content of both
siControl and siAcsl4-treated cells (Fig. 4A). The addition of
exogenous oleate to siAcsl4 cells had no effect on any of the
individual acyl-CoAs, relative to siControl cells (Fig. 4C). How-
ever, adding exogenous AA to siAcsl4 cells specifically reduced
arachidonyl-CoA, relative to siControl cells (Fig. 4D), confirm-
ing the knownAA substrate preference of Acsl4 (32). Because it
was necessary to add exogenous AA to observe the reduced
arachidonyl-CoA in the siAcsl4 cells and because the content of
long chain acyl-CoAs did not change, especially in the vehicle-
treated cells, these findings suggest that long chain acyl-CoAs
do not regulate insulin release directly. Instead, insulin secre-
tion appeared to be mediated by a lipid intermediate whose
levels were altered by Acsl4.
Acsl4Modulates Epoxyeicosatrienoic Acid Incorporation into
Cell Membranes—To determine the lipid intermediates
responsible for reduced GSIS, we profiled AA metabolites
in the media from Acsl4 knockdown cells. The media from
siControl or siAcsl4-treated cells did not contain significantly
different levels of prostaglandins, thromboxanes, or HETEs
(Fig. 5, A and B). However, compared with media from the
siControl cells, media from the siAcsl4 cells contained 81%
more total EETs (Fig. 5C). Likewise, compared with the siCon-
trol cells, the cell membranes from siAcsl4 cells contained 69%
less total EETs (Fig. 5D). TheAcsl4 knockdown did not alter the
mRNA expression of soluble epoxide hydrolase (Ephx2) or
cytochrome P-450 2j4 (Cyp2j4), the enzymes responsible for
the degradation and synthesis of EETs, respectively (Fig. 5E).
Additionally, the amounts of dihydroxyeicosatrienoic acids
(DHETs), the breakdown products of EETs by soluble epoxide
hydrolase (sEH), were elevated in the siAcsl4 cells to the same
FIGURE 2. Acsl4 siRNA knockdown in INS 832/13 cells reduced Acsl4 mRNA expression, Acsl4 protein expression, acyl-CoA synthetase activity,
glucose-stimulated insulin secretion, and fatty acid augmented insulin secretion. A, two separate siRNAs targeted against Acsl4 reduced mRNA expres-
sion by more than 75%. B, corresponding reduction of Acsl4 protein expression with Acsl4 siRNA knockdown by two independent Acsl4 siRNAs. Duplicate
samples were examined with knockdown of 80% for each Acsl4 siRNA as quantified by densitometry relative to Gapdh loading control. A.U., arbitrary units.
C, Acsl specific activity from siControl and siAcsl4-treated INS 832/13 cells with AA, palmitate (PA), and oleate (OA) as substrates. D, glucose-stimulated insulin
secretion with or without KCl and fatty acid augmented insulin secretion with 2:1 oleate/palmitate (OA/PA) at the concentrations indicated. The results
represent means  S.E. of three separate experiments carried out at least in triplicate. *, p  0.05 relative to siControl.
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extent as the free EETs (Fig. 5F), suggesting that Acsl4 knock-
down did not alter sEH activity.
EETs are incorporated into the sn-2 position of glycerophos-
pholipids through a CoA-dependent process (35, 36). Our data
suggest that Acsl4 is the isoform responsible for activating
EETs to form EET-CoAs, thereby facilitating their esterifica-
tion into glycerophospholipids by an as yet unknown acyltrans-
ferase. To confirm the ability of Acsl4 to use EETs as substrates,
we measured the activity of purified rat Acsl4 with each of the
four EET species. All EETs were substrates for Acsl4 (Fig. 5G).
Although the specific activity of rat Acsl4 with EETs was 50%
lower than with AA, distinct EET preferences were observed.
Rat Acsl4 preferred 8,9-EET  14,15-EET  5,6-EET  11,12-
EET. Taken together, these results suggest that Acsl4 activates
EETs before they are esterified into glycerophospholipids.
EETs Inhibit GSIS and Inhibiting EET Actions Rescue the
Reduced GSIS of Acsl4 Knockdown—Because knockdown of
Acsl4 increased free EETs in the media, we asked whether the
FIGURE 3. Incorporation of oleate into INS 832/13 cellular lipids was not affected by Acsl4 knockdown; however, Acsl4 knockdown reduced incorpo-
ration of AA into neutral lipid while preserving phospholipid levels. Acsl4 knockdown did not affect palmitate (PA) oxidation. A, C, and E, oleate (OA)
incorporation into total cellular lipids (A), neutral lipids (C), and phospholipids (E). B, D, and F, AA incorporation into total cellular lipids (B), neutral lipids (D), and
phospholipids (F). G and H, PA incorporation into CO2 (G) and PA incorporation into acid-soluble metabolites (ASM) (H). CE, cholesterol esters; TAG, triacylg-
lycerol; DAG, diacylglycerol; PE, phosphatidylethanolamine; PC, phosphatidylcholine; PI/S, combination of phosphatidylinositol/phosphatidylserine. The val-
ues are reported as means  S.E. from three separate experiments carried out at least in triplicate. *, p  0.05 relative to siControl.
Role of Acyl-CoA Synthetases in GSIS
JULY 26, 2013 • VOLUME 288 • NUMBER 30 JOURNAL OF BIOLOGICAL CHEMISTRY 21623
unesterified EETs provided a mechanism for the reduced insu-
lin secretion observed when Acsl4 activity was decreased. We
used the EET concentrations (1 M) that were previously used
in rat islet experiments (17). At basal glucose concentrations,
the EET species did not alter insulin secretion (Fig. 6A). How-
ever compared with vehicle-exposed cells at 17 mM glucose,
5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EET each diminished
insulin secretion by as much as 30%. Apart from 8,9-EET, the
effect was lost when 40 mM KCl was added. It is likely that
exogenous application of EETs did not diminish insulin secre-
tion as strongly as observedwith theAcsl4 knockdown (Fig. 2D)
because the exogenous addition did not directly target the EETs
to the insulin secretion machinery within the cell.
To further confirm the role of EETs on GSIS, we exposed
siControl and siAcsl4-treated cells to 14,15-EEZE, an antago-
nist to the putative EET receptor (37). 14,15-EEZE increased
insulin secretion 28 and 57% at 3 and 17 mM glucose, respec-
tively, in the siAcsl4 cells (Fig. 6B), supporting the idea that
EETs suppress insulin secretion. Taken together, these results
suggest that 5,6-, 8,9-, 11,12-, and 14,15-EETs inhibit GSIS and
that inhibiting EET action rescues the ability of siAcsl4 cells to
secrete insulin in the presence of a stimulatory concentration of
glucose.
Incubating INS 832/13Cells with Polyunsaturated Fatty Acid
(PUFA) Reduced Both Acsl4 Expression and GSIS—Chronic
exposure of INS 832/13 cells to exogenous FA reduces GSIS
(28). To determine the effect of FA on Acsl4 expression, we
incubated INS 832/13 cells with 0.5–1 mM concentrations of
either oleate:palmitate (2:1 unsaturated:saturated molar ratio)
or oleate:palmitate:AA (6:3:1 molar ratio) for 72 h. AA was
added to the oleate:palmitate incubation because PUFAs are
present in the typical Western diet and associated with meta-
FIGURE 4. Knockdown of Acsl4 did not change cellular total acyl-CoA levels except with the addition of exogenous AA where Acsl4 knockdown
reduced arachidonoyl-CoA levels. A, effect of Acsl4 knockdown in INS 832/13 cells on total CoA species after a 4-h incubation with either vehicle or 50 M
oleate (OA) or 50 M AA (final concentration). B, long chain acyl-CoA species from vehicle control. C, long chain acyl-CoA species from 50 M oleate treated cells.
D, long chain acyl-CoA species from 50 M arachidonate-treated cells. 16:1-CoA, palmitoleoyl-CoA; 16:0-CoA, palmitoyl-CoA; 18:3-CoA, linolenoyl-CoA; 18:2-CoA,
linoleoyl-CoA; 18:1-CoA, oleoyl-CoA; 18:0-CoA, stearoyl-CoA; 20:4-CoA, arachidonoyl-CoA; 20:1-CoA, eicosanoyl-CoA; 20-CoA, arachidoyl-CoA. The values are
reported as means  S.E. from three separate experiments carried out in triplicate. *, p  0.05 relative to siControl.
Role of Acyl-CoA Synthetases in GSIS
21624 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288 • NUMBER 30 • JULY 26, 2013
bolic disease (38). Although the oleate:palmitate combination
had no effect on Acsl4 protein expression, the combination of
oleate:palmitate:AA resulted in 50% reduction in Acsl4 pro-
tein expression (data not shown). Thus, at plausible physiologic
concentrations of AA (50 M) (38), Acsl4 protein expression
was reduced. When INS 832/13 cells were incubated for 72 h
with 10, 25, or 50 M palmitate, oleate, AA, or linoleate, the AA
and linoleate reduced Acsl4 mRNA expression (Fig. 7A) and
Acsl4 protein expression (Fig. 7B) in a dose-dependentmanner.
This reduction in Acsl4 expression corresponded to a 20%
reduction in GSIS at 3 mM glucose and 40% reduction at 17
mM glucose (Fig. 7C). These experiments indicate that PUFAs
decrease Acsl4 expression, which then reduces GSIS similar to
the reduction observed with selective knockdown of Acsl4.
DISCUSSION
The major finding of this study is that unesterified EETs
inhibit GSIS. Acsl4 promotes GSIS by producing EET-CoAs
that are then esterified into glycerolipids. Previous studies to
determine the role of long chain acyl-CoAs in GSIS used triac-
sin C, an inhibitor of acyl-CoA synthetase activity, but yielded
conflicting results (39, 40). Because inhibiting acyl-CoA synthe-
FIGURE 5. Acsl4 knockdown did not alter the formation of thromboxanes, prostaglandins, or HETEs. However, knockdown of Acsl4 increased media EET
levels, whereas cellular membrane EET levels were reduced. Acsl4 knockdown increased the formation of DHETs, indicating that sEH activity is intact. Purified
rat Acsl4 is able to use EETs as a substrate. A, thromboxane B2 (TXB2), prostaglandin D2 (PGD2), and prostaglandin B2 (PGB2) levels in media surrounding INS
832/13 cells after knockdown of Acsl4. B, HETE levels in media surrounding INS 832/13 cells after knockdown of Acsl4. C, EET levels in media surrounding INS
832/13 cells after knockdown of Acsl4. D, cellular membrane content of EET levels in INS 832/13 cells after knockdown of Acsl4. E, effect of Acsl4 knockdown on
the mRNA expression of Ephx2 and Cyp2j4. F, DHET levels in media surrounding INS 832/13 cells after knockdown of Acsl4. G, purified rat Acsl4 enzyme specific
activity using AA and EETs as substrates. The values are reported as means  S.E. from two separate experiments carried out at least in triplicate. *, p  0.05
relative to siControl. Because the ability to detect 11,12-EET was not sufficiently sensitive, these data are not shown in C and D.
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tase activity with triacsin C reduced insulin secretion in one of
these studies, it was thought that long chain acyl-CoAs them-
selves were important mechanistically in coupling FA metabo-
lism and augmented insulin secretion (40). Our studies suggest,
instead, that an eicosanoid substrate of Acsl4 is an inhibitor.
Despite previous studies that concluded that acyl-CoAswere
important for insulin secretion, no studies have directly evalu-
ated the role of acyl-CoA synthetases in insulin secretion. Acyl-
CoA synthetases have different substrate preferences, enzyme
kinetics, subcellular locations, and tissue-specific expression
(18). Using a beta-cellmodel, INS 832/13 cells, we found that, of
the five Acsl isoforms, the mRNAs forAcsl4 andAcsl5were the
most prominent. To determine the role of acyl-CoA syntheta-
ses in INS 832/13 cells, we selectively knocked down either
Acsl4 orAcsl5 using siRNAs. KnockdownofAcsl5 did not result
in changes in GSIS, indicating that Acsl5 and its resultant acyl-
CoA products do not play a direct role in GSIS. However, the
knockdown of Acsl4 resulted in reduced GSIS without changes
in acyl-CoA content, indicating that the mechanism for the
reduced GSIS was not via a lack of either a specific long chain
acyl-CoA or a pool of acyl-CoAs synthesized by Acsl4.
GSIS is a complicated process involving the metabolism of
glucose leading to a rise in ATP, depolarization events, insulin
granule translocation, and insulin exocytosis. Our data indicate
that the role of Acsl4 and EETs in the GSIS cascade is distal to
the depolarization event because GSIS in siAcsl4-treated cells
was reduced with 40mMKCl treatment.With a rise in intracel-
lular calcium, cytosolic phospholipase A2 is activated leading to
hydrolysis of lipids from the sn-2 position of glycerophospho-
lipids. Under normal conditions, the AA that is metabolized by
the cytochrome P450 (CYP) pathway to produce EETs, or the
EETs that are released from glycerophospholipids by lipases
serve to dampen insulin secretion, thus preventing untoward
insulin release and hypoglycemia. The levels of free EETs are
modulated either by rapid inactivation by sEH or by re-esteri-
fication byAcsl4. If, however, Acsl4 is absent, the concentration
FIGURE 6. INS 832/13 cells exposed to EETs reduced GSIS and an inhibitor of EET action partially rescued the impaired GSIS in Acsl4 knockdown cells.
A, Reduced GSIS in INS 832/13 cells exposed to EETs () 5,6-, 8,9-, 11,12-, or 14,15-EET at 1 M final concentration with or without 40 mM KCl. B, reduced GSIS
by Acsl4 knockdown was partially rescued with the addition of 10 M 14,15-EEZE, an antagonist to the putative EET receptor. The values are reported as
means  S.E. from three separate experiments carried out at least in triplicate. *, p  0.05 relative to siControl. The bar indicates difference between
siAcsl4-treated cells exposed to EEZE relative to vehicle.
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of free EETs increases and diminishes GSIS (Fig. 8). Thus, in
siAcsl4 cells, the reduction in GSIS appears to result from
increased levels of unesterified EETs. Our studies strongly sug-
gest that Acsl4 normally synthesizes EET-CoAs that are incor-
porated into glycerophospholipids (35, 36), therebymoderating
any rise in EETs. Our data suggest that the sequestration of
FIGURE 7. Incubation of INS 832/13 cells with AA or linoleate reduced, in a dose-dependent manner, the expression of Acsl4 mRNA and protein that
caused a reduction in glucose-stimulated insulin secretion. A, Acsl4 mRNA expression in INS 832/13 cells exposed to 10, 25, or 50 M oleate (OA), AA, or
linoleate (LA) for 72 h. B, representative Western blot of corresponding Acsl4 protein expression in INS 832/13 cells exposed to 10, 25, or 50 M palmitate (PA),
oleate, arachidonate, or linoleate for 72 h. Acsl4 protein expression in the 50 M AA- and LA-treated cells is reduced by 70% relative to vehicle-treated cells
as quantified by densitometry relative to Gapdh loading control. A.U., arbitrary units. C, glucose-stimulated insulin secretion in 832/13 cells exposed to 10, 25,
or 50 M oleate, arachidonate, or linoleate for 72 h with or without 40 mM KCl. The values are reported as means  S.E. from three separate experiments carried
out at least in triplicate. *, p  0.05 relative to vehicle.
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EETs into glycerophospholipids is a major route of metabolism
of EETs in INS 832/13 cells.
Our finding that EETs inhibit insulin secretion contrasts
with a previous study showing that 5,6-EET increases insulin
secretion from rat islets (17). In this study, however, 8,9-EET,
11,12-EET, and 14,15-EET increased glucagon secretion, but
not insulin secretion. Additionally, the insulin stimulatory
effect seen with 5,6-EETmay not be due to EET-like effects but
rather to a prostaglandin-like effect because 5,6-EET is con-
verted to 5,6-epoxy-prostaglandin E1 (41), and exogenous pros-
taglandins stimulate GSIS (42–44). The differences in these
studies are most likely due to the presence of glucagon-secret-
ing alpha-cells in the rat islets, in contrast to our studies with a
pure beta-cell line. Another study inmice lacking soluble epox-
ide hydrolase (45), the enzyme that converts EET to inactive
DHET, suggested that EETs might stimulate insulin secretion;
membrane and free EETs, however, were not measured in this
study. Our data in a beta-cell model suggest that, despite nor-
mal sEHactivity asmeasured byDHETproduction, the absence
of Acsl4 allowed EETs to accumulate and reduce insulin
secretion.
The uptake and storage of FA metabolites has been impli-
cated as a cause of beta-cell dysfunction. However, most exper-
iments have used supraphysiologic levels of FA, usually palmi-
tate, which is toxic when given alone to cells (46, 47). We show
here that chronic exposure (72 h) at a physiologic level of the
omega-6 PUFAs AA or linoleate to INS 832/13 cells reduces
Acsl4 expression in a dose-dependent manner together with a
reduction in GSIS. These findings open the possibility that, in
addition to other environmental factors, a specific class of FA
contributes to the development of diabetes by reducing Acsl4
expression, whose activity moderates the content of specific
oxidized lipid metabolites (EETs), thereby leading to decreased
insulin secretion.
Our study shows that Acsl isoform 4, which activates AA and
EETs, enhances GSIS. The fact that EETs diminish GSIS in INS
832/13 cells suggests that this effect must be regulated by con-
verting EETs into EET-CoAs that can then be sequestered in
glycerophospholipids and that optimal GSIS is maintained by
this cycle of EETmetabolism. The data presented here shift the
paradigm that lipid intermediates stimulate insulin secretion to
one identifying specific lipid intermediates that act as repres-
sors of insulin secretion.
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